Harpoon Therapeutics, Inc. (HARP) Sof foyda bo'yicha sotuv rentabelligi

Harpoon Therapeutics (HARP) tovar belgisi

Harpoon Therapeutics kasallikni immun tizimi uchun ko'rinadigan qilish orqali qattiq o'smalarga qarshi kurashish uchun yuqori aniqlikdagi antitanalarni ishlab chiqadi. Ushbu strategiya uzoq muddatli monetizatsiyaga ega patent himoyasini yo'lga qo'yishga asoslangan. Merck doirasida kompaniya trispesifik dori vositalarini ishlab chiqmoqda. Sof foyda marjasi biznesning tashqi zarbalarga chidamliligini namoyish etadi, bunda ko'rsatkich -81.70 ga yetib, joriy foyda tendentsiyasini bildiradi.

HARP: Harpoon Therapeutics Corp Kompaniyaning sof rentabelligi 04.07.2022 - 16.03.2024

Harpoon Therapeutics kompaniyasining tahliliy kesimlari

- bozor qiymati va tahlilchilarning maqsadli prognozi:
Kompaniyaning jamlanma tahliliyoti:harpoontx.com - HARP
Harpoon Tx yetakchi tovari

Harpoon Therapeutics (HARP) onkologiya aktivlarining Merck tuzilmasiga integratsiyasi FDA operatsion risklarini minimallashtirdi. Savdo marjasi tushumda sof foydaning ulushini o'lchaydi va daromadni real kapitalga aylantirish samaradorligini belgilaydi. Ushbu ko'rsatkichning dinamikasi turbulentlik davrlarida biznesning yashirin xavfsiz boshpanasini ochib beradi. Kundalik monitoring vaqtincha pasayishlar va tizimli inqirozni farqlash imkonini beradi. Sof foyda marjasi tahlili investorlarga zararlarning muddatidan oldin kristallanishidan qochishga yordam beradi.

Raqobatchilar tahlili

NantKwest (IBRX) - Sof marja|Sof marja Immunocore PLC (IMCR)|Sof foyda bo'yicha sotuv rentabelligi JANX|RCUS - Sof foyda bo'yicha marjinallik|Sof foyda bo'yicha sotuv rentabelligi ZYME (Zymeworks Corp)|Kompaniyaning sof rentabelligi TNGX|Sotuvning sof marjinal rentabelligi IOVA (Iovance Biotherapeutics, Inc.)|Sof foyda normasi IMTX|xencor.com - Sotuvning sof marjinal rentabelligi|Sof marja Compass Therapeutics Corp|Replimune Group, Inc. (REPL) - Sof marja|Lyell Immunopharma - Sof foyda normasi|IPHA (innate-pharma.com) - Sotuvning sof marjinal rentabelligi|Sotuvning sof marjinal rentabelligi pyxisoncology.com|Sof marja cgen.com (CGEN)|IOBT: Sof foyda marjasi|Sutro Biopharma Inc. - Sof foyda bo'yicha sotuv rentabelligi|minktherapeutics.com (INKT) - Sof marja|HOWL: Sof foyda bo'yicha sotuv rentabelligi|Kompaniya sotuv marjasi Immix Biopharma IMMX|ALX Oncology (ALXO) - Sof marja|Sof marja Cue Biopharma, Inc. (CUE)|Sof marja PDS Biotechnology Corporation|Sotuvning sof rentabelligi SONN (sonnetbio.com)|Sotuvning sof marjinal rentabelligi MAIA|Kompaniya sotuv marjasi Liminatus Pharma Inc.|LAVA Therapeutics N.V. - Sof foyda bo'yicha sotuv rentabelligi|NXTC - Sof foyda bo'yicha sotuv rentabelligi|LPTX: Sof foyda bo'yicha sotuv rentabelligi|Kompaniya sotuv marjasi intensitytherapeutics.com INTS|SNSE (Sensei Bio) - Sof foyda bo'yicha sotuv rentabelligi|Synthetic Biologics (TOVX) - Sotuvning sof marjinal rentabelligi|Sof marja Gritstone bio|Sof foyda bo'yicha sotuv rentabelligi Kineta, Inc. (KA)|Sotuvning sof marjinal rentabelligi NEXI|TSBX - Sof marja|Sotuvning sof marjinal rentabelligi VCNX (Vaccinex Inc.)